Mackenzie Financial Corp Exact Sciences Corp Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

A detailed history of Mackenzie Financial Corp transactions in Exact Sciences Corp stock. As of the latest transaction made, Mackenzie Financial Corp holds 1,405,452 shares of EXAS stock, worth $74.1 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

1,405,452

Previous 11,535 12084.24%

Holding current value

$74.1 Million

Previous $487,000 19550.31%

% of portfolio

0.14%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$42.43 - $70.83 $59.1 Million - $98.7 Million	1,393,917 Added 12084.24%	1,405,452 $95.7 Million
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $96,092 - $172,654	2,325 Added 25.24%	11,535 $487,000
Q1 2024 May 10, 2024	SELL	$56.27 - $73.77 $170,948 - $224,113	-3,038 Reduced 24.8%	9,210 $636,000
Q4 2023 Jan 30, 2024	SELL	$59.06 - $75.72 $48,547 - $62,241	-822 Reduced 6.29%	12,248 $906,000
Q3 2023 Oct 25, 2023	BUY	$65.94 - $99.04 $211,008 - $316,928	3,200 Added 32.42%	13,070 $891,000
Q2 2023 Aug 03, 2023	BUY	$62.68 - $95.05 $618,651 - $938,143	9,870 New	9,870 $926,000
Q2 2022 Aug 10, 2022	SELL	$35.61 - $76.23 $273,556 - $585,598	-7,682 Reduced 53.33%	6,724 $265,000
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $460 - $660	8 Added 0.06%	14,406 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $43,862 - $60,911	605 Added 4.39%	14,398 $1.12 Million
Q3 2021 Nov 08, 2021	BUY	$90.24 - $124.05 $185,352 - $254,798	2,054 Added 17.5%	13,793 $1.32 Million
Q2 2021 Aug 11, 2021	BUY	$93.66 - $139.27 $56,383 - $83,840	602 Added 5.41%	11,739 $1.46 Million
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $413,124 - $549,355	3,544 Added 46.67%	11,137 $1.47 Million
Q4 2020 Feb 10, 2021	BUY	$99.61 - $142.12 $331,103 - $472,406	3,324 Added 77.86%	7,593 $1.01 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $116,307 - $162,705	-1,595 Reduced 27.2%	4,269 $435,000
Q2 2020 Aug 13, 2020	BUY	$55.75 - $92.75 $114,176 - $189,952	2,048 Added 53.67%	5,864 $509,000
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $26,113 - $71,959	689 Added 22.03%	3,816 $221,000
Q4 2019 Feb 13, 2020	SELL	$77.66 - $99.74 $239,969 - $308,196	-3,090 Reduced 49.7%	3,127 $289,000
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $275,086 - $372,859	-3,044 Reduced 32.87%	6,217 $562,000
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $157,358 - $207,514	-1,758 Reduced 15.95%	9,261 $1.09 Million
Q1 2019 May 15, 2019	BUY	$61.98 - $96.5 $364,132 - $566,937	5,875 Added 114.21%	11,019 $954,000
Q4 2018 Feb 06, 2019	BUY	$56.04 - $82.66 $1,288 - $1,901	23 Added 0.45%	5,144 $325,000
Q3 2018 Nov 15, 2018	BUY	$48.29 - $80.6 $47,227 - $78,826	978 Added 23.61%	5,121 $404,000
Q2 2018 Aug 13, 2018	SELL	$37.84 - $69.96 $228,629 - $422,698	-6,042 Reduced 59.32%	4,143 $248,000
Q1 2018 May 14, 2018	BUY	$39.82 - $57.53 $405,566 - $585,943	10,185 New	10,185 $411,000

Others Institutions Holding EXAS

# of Institutions

670

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.33B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Exact Sciences Corp Transaction History